UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 113

Sortiert nach

MicroRNA‐155‐5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway

Cancer science, 2017-04, Vol.108 (4), p.620-631

2017

Link zum Volltext

Verfügbarkeit prüfen

Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway

Journal of experimental & clinical cancer research, 2018-03, Vol.37 (1), p.52-52

2018

Link zum Volltext

Verfügbarkeit prüfen

Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy

Cancer science, 2018-10, Vol.109 (10), p.3055-3067

2018

Link zum Volltext

Verfügbarkeit prüfen

Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy

Medical oncology (Northwood, London, England), 2019-10, Vol.36 (10), p.84-6, Article 84

2019

Link zum Volltext

Verfügbarkeit prüfen

Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: estimates from global burden of disease study in 2017

Annals of medicine (Helsinki), 2022-12, Vol.54 (1), p.633-645

2022

Link zum Volltext

Verfügbarkeit prüfen

Autophagy in the “inflammation-carcinogenesis” pathway of liver and HCC immunotherapy

Cancer letters, 2017-12, Vol.411, p.82-89

2017

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA‐760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1‐PTEN/Akt Signaling Pathway

Journal of biochemical and molecular toxicology, 2018-08, Vol.32 (8), p.e22167-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Colon cancer cells secreted CXCL11 via RBP‐Jκ to facilitated tumour‐associated macrophage‐induced cancer metastasis

Journal of cellular and molecular medicine, 2021-11, Vol.25 (22), p.10575-10590

2021

Link zum Volltext

Verfügbarkeit prüfen

Associations of components of PTEN/AKT/mTOR pathway with cancer stem cell markers and prognostic value of these biomarkers in hepatocellular carcinoma

Hepatology research, 2016-12, Vol.46 (13), p.1380-1391

2016

Link zum Volltext

Verfügbarkeit prüfen

Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway

Oxidative medicine and cellular longevity, 2019, Vol.2019, p.5813985-12

2019

Link zum Volltext

Verfügbarkeit prüfen

CNV Detection from Circulating Tumor DNA in Late Stage Non-Small Cell Lung Cancer Patients

Genes, 2019-11, Vol.10 (11), p.926

2019

Link zum Volltext

Verfügbarkeit prüfen

A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS -Mutant Advanced Lung Adenocarcinoma

Frontiers in oncology, 2020-09, Vol.10, p.559896-559896

2020

Link zum Volltext

Verfügbarkeit prüfen

miRNA-302b suppresses human hepatocellular carcinoma by targeting AKT2

Molecular cancer research, 2014-02, Vol.12 (2), p.190-202

2014

Link zum Volltext

Verfügbarkeit prüfen

Oxidative stress upregulates PDCD4 expression in patients with gastric cancer via miR-21

Current pharmaceutical design, 2014-04, Vol.20 (11), p.1917

2014

Link zum Volltext

Verfügbarkeit prüfen

Green synthesis of copper nanoparticles using Cinnamomum zelanicum extract and its applications as a highly efficient antioxidant and anti-human lung carcinoma

Journal of experimental nanoscience, 2021-01, Vol.16 (1), p.410-423

2021

Link zum Volltext

Verfügbarkeit prüfen

Depression accelerates the development of gastric cancer through reactive oxygen species-activated ABL1 (Review)

Oncology reports, 2016-11, Vol.36 (5), p.2435-2443

2016

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment

Cancer biology & medicine, 2018-11, Vol.15 (4), p.443-451

2018

Link zum Volltext

Verfügbarkeit prüfen

Down‐regulation of the cyclin‐dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis

Hepatology (Baltimore, Md.), 2016-03, Vol.63 (3), p.898-913

2016

Link zum Volltext

Verfügbarkeit prüfen

Retraction Note: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway

Journal of experimental & clinical cancer research, 2023-07, Vol.42 (1), p.174-174, Article 174

2023

Link zum Volltext

Verfügbarkeit prüfen

Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients

Frontiers in genetics, 2020-08, Vol.11, p.899-899

2020

Link zum Volltext

Verfügbarkeit prüfen

Management of anlotinib‐related adverse events in patients with advanced non‐small cell lung cancer: Experiences in ALTER‐0303

Thoracic cancer, 2019-03, Vol.10 (3), p.551-556

2019

Link zum Volltext

Verfügbarkeit prüfen

Identification and characterization of CAC1 as a novel CDK2-associated cullin

Cell cycle (Georgetown, Tex.), 2009-11, Vol.8 (21), p.3552-3561

2009

Link zum Volltext

Verfügbarkeit prüfen

p57: A multifunctional protein in cancer (Review)

International journal of oncology, 2010-06, Vol.36 (6), p.1321-1329

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of anlotinib as a third‐ or further‐line therapy in advanced non‐small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial

Cancer medicine (Malden, MA), 2020-04, Vol.9 (8), p.2621-2630

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study

The lancet oncology, 2017-09, Vol.18, p.S3-S3

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(58)
Humans
(46)
Oncology
(36)
Female
(30)
Middle Aged
(26)
Male
(24)
Cell Line, Tumor
(19)
Aged
(17)
Adult
(14)
Gene Expression Regulation, Neoplastic
(13)
Prognosis
(13)
Animals
(12)
Hepatocellular Carcinoma
(11)
Lung Cancer
(11)
Apoptosis
(10)
Neoplasm Staging
(10)
Original
(10)
Carcinoma, Hepatocellular - Pathology
(9)
Liver Neoplasms - Pathology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MicroRNA‐155‐5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway

Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway

Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy

Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy

Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: estimates from global burden of disease study in 2017

Autophagy in the “inflammation-carcinogenesis” pathway of liver and HCC immunotherapy

MicroRNA‐760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1‐PTEN/Akt Signaling Pathway

Colon cancer cells secreted CXCL11 via RBP‐Jκ to facilitated tumour‐associated macrophage‐induced cancer metastasis

Associations of components of PTEN/AKT/mTOR pathway with cancer stem cell markers and prognostic value of these biomarkers in hepatocellular carcinoma

Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway

CNV Detection from Circulating Tumor DNA in Late Stage Non-Small Cell Lung Cancer Patients

A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS -Mutant Advanced Lung Adenocarcinoma

miRNA-302b suppresses human hepatocellular carcinoma by targeting AKT2

Oxidative stress upregulates PDCD4 expression in patients with gastric cancer via miR-21

Green synthesis of copper nanoparticles using Cinnamomum zelanicum extract and its applications as a highly efficient antioxidant and anti-human lung carcinoma

Depression accelerates the development of gastric cancer through reactive oxygen species-activated ABL1 (Review)

Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment

Down‐regulation of the cyclin‐dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis

Retraction Note: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway

Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients

Management of anlotinib‐related adverse events in patients with advanced non‐small cell lung cancer: Experiences in ALTER‐0303

Identification and characterization of CAC1 as a novel CDK2-associated cullin

p57: A multifunctional protein in cancer (Review)

Effect of anlotinib as a third‐ or further‐line therapy in advanced non‐small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial

Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study

Suchergebnisse filtern